Tenet Healthcare THC Gain/Loss on Asset Sales
Gain/Loss on Asset Sales at other companies
Other financials
Where this comes from
Reported directly by Tenet Healthcare in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.
The official record: Tenet Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tenet Healthcare's gain/loss on asset sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tenet Healthcare's gain/loss on asset sales?
- Tenet Healthcare (THC) reported gain/loss on asset sales of $1M in Q1 2026.
- What is the long-term trend for Tenet Healthcare's gain/loss on asset sales?
- Over 4 years (2021 to 2025), Tenet Healthcare's gain/loss on asset sales has grown at a -35.4% compound annual growth rate (CAGR), from $23M to $4M.
- What does gain/loss on asset sales mean?
- The accounting gain or loss recorded when selling company assets.
- How do you interpret gain/loss on asset sales?
- A gain indicates successful divestiture at a premium, while a loss may suggest asset impairment or strategic exit from underperforming business lines.
- How does gain/loss on asset sales compare across companies?
- Commonly reported by healthcare providers undergoing portfolio optimization or hospital divestitures.